dc.contributor.author | Sud, A | |
dc.date.accessioned | 2017-09-21T10:51:55Z | |
dc.date.issued | 2017-06-01 | |
dc.identifier.citation | International journal of hematologic oncology, 2017, 6 (1), pp. 5 - 8 | |
dc.identifier.issn | 2045-1393 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/837 | |
dc.identifier.eissn | 2045-1407 | |
dc.identifier.doi | 10.2217/ijh-2017-0008 | |
dc.description.abstract | Amit Sud speaks to Sebastian Dennis-Beron, Commissioning Editor: Amit Sud is a clinical research fellow in Hematology at the Institute of Cancer Research, UK. He undertook his undergraduate medical training at the University of Manchester, gaining an honors degree. He completed his Masters in Medical Research at Manchester University, gaining a distinction. He continued his medical training in Manchester and London and started his specialization in Hematology in South West London. He was successful in obtaining a Cancer Research UK funded clinical research fellowship in Hematology under the supervision of Professor Richard Houlston at the Institute of Cancer Research. His current research focus is that of genetic susceptibility to Hodgkin lymphoma. He is a trainee member of the NCRI Lymphoma Clinical Studies Group. | |
dc.format | Print-Electronic | |
dc.format.extent | 5 - 8 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | Future Medicine Ltd | |
dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
dc.title | Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2017-03-30 | |
rioxxterms.funder | The Institute of Cancer Research | |
rioxxterms.identifier.project | Unspecified | |
rioxxterms.versionofrecord | 10.2217/ijh-2017-0008 | |
rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2017-06-30 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | International journal of hematologic oncology | |
pubs.issue | 1 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics | |
pubs.publication-status | Published | |
pubs.volume | 6 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Cancer Genomics | |
dc.contributor.icrauthor | Sud, Amit | |